LipedemaCare

Why does constipation happen in lipedema, and how can it be managed?

Prof.Dr. Mustafa SAÇAR

People with lipedema often describe constipation simply as not being able to go to the toilet. In reality, constipation is broader: slower bowel movement, hard stools, straining, incomplete evacuation, abdominal bloating and post-meal heaviness may all be part of the picture. Lipedema itself is not a bowel disease, but pain, reduced movement, dietary changes, stress, fluid-electrolyte balance and the gut microbiota can all influence bowel rhythm.

The microbiota is the ecosystem of bacteria, fungi and other microorganisms living in the gut. Research directly studying gut microbiota in lipedema is still new. A pilot study by Di Renzo and colleagues suggests that the gut microbiota profile in women with lipedema deserves further investigation, but it does not prove that microbiota is the only cause of constipation (Di Renzo et al., 2025). For the wider topic, see lipedema and gut health.

How does constipation develop in the bowel?

The digestive and elimination system can be thought of as a coordinated movement pathway. In the colon, water is reabsorbed while stool moves forward. If transit slows, stool stays in the colon longer, loses more water and becomes harder. The person may then pass stool less often, strain more or feel that evacuation is incomplete.

Bowel movement is influenced by the nervous system, intestinal muscles, hormones, bile acids, short-chain fatty acids, fiber, water and microbiota. Recent reviews on chronic constipation and microbiota describe that microbiota changes may be related to intestinal transit, stool consistency and gas production in some people (Xu et al., 2024). The relationship can also work both ways: slow transit may change the microbiota too.

Why can constipation be more noticeable in lipedema?

Pain, heaviness and fear of worsening discomfort can reduce daily activity in some people with lipedema. When movement decreases, bowel motility may also slow. Low-impact walking, water exercise or gentle resistance training can support not only the muscle pump but also bowel rhythm. The movement guidance in lipedema exercises is relevant here.

Dietary transition is another common reason. Low-carbohydrate or ketogenic approaches may help some patients with appetite, blood sugar or symptom management, but if the transition is not planned well, fiber, water and electrolytes may drop. Fiber adds bulk to stool and some types are fermented by gut bacteria. If fiber falls too low, stool volume may decrease and bowel movements may become less frequent. That is why keto and low-carb diet should be planned with vegetables, water, salt, magnesium and personal tolerance in mind.

How do microbiota, inflammation and constipation connect?

The gut microbiota can ferment fiber and produce short-chain fatty acids. These are small metabolites, meaning small compounds produced during metabolism. Short-chain fatty acids may affect the gut barrier, immune signaling and intestinal movement. Metabolomics reviews in functional constipation describe links between short-chain fatty acids, bile acid metabolism, motility and inflammation (Zheng et al., 2025).

Inflammation should be explained carefully. Constipation is not the cause of lipedema, and lipedema does not automatically cause constipation in every patient. Still, increased gut permeability, microbiota shifts, gas and bloating, insulin resistance, stress and poor sleep can overlap in the same person. A patient may feel this as abdominal bloating, leg heaviness, post-meal fatigue and irregular bowel habits.

Why water, electrolytes and magnesium matter

Drinking water alone does not always solve constipation, but low fluid intake can make it worse. During low-carbohydrate eating, the body may lose more water and sodium at the beginning. Electrolytes such as sodium, potassium and magnesium support nerve and muscle function. Regular contraction of intestinal muscles is also part of this system.

Magnesium may help soften stools in selected patients, but it should not be used casually in kidney disease, diarrhea tendency or complex medication use. Chronic constipation guidelines review fiber, osmotic laxatives and medication options according to evidence strength; therefore, persistent constipation should not be managed with repeated unsupervised laxative use (Chang et al., 2023). Supplements are discussed in lipedema supplements.

A practical and safe management approach

The first step is to understand when constipation began. If it started after a new diet, iron supplement, pain medicine, antidepressant, calcium supplement or a less active period, the cause may be easier to identify. Stool frequency, hardness, straining, abdominal pain, bloating and incomplete evacuation can be tracked for a few weeks.

A practical plan often begins with more fiber-rich vegetables, adequate protein, not cutting healthy fats too aggressively, spreading water through the day, maintaining salt and electrolytes, and moving gently but regularly. Fermented foods and probiotics may help some patients, but not everyone responds the same way. If bloating worsens, the type, dose and timing should be reconsidered. For nutrition, see lipedema nutrition and nutrition tips for lipedema patients.

When should constipation be evaluated medically?

Medical assessment is needed when constipation is new or worsening, or when there is blood in the stool, unexplained weight loss, anemia, fever, night-time abdominal pain, vomiting, severe abdominal swelling or a major change in bowel habits. New constipation after age 50 should also be taken more seriously.

In a patient with lipedema, constipation can often be improved by adjusting nutrition, movement, fluids and bowel routine. But not every episode should be attributed to the lipedema plan. Hypothyroidism, diabetes, neurologic conditions, medications and bowel disorders should be considered when appropriate. For weight-related confusion, see lipedema vs obesity.

Summary

Constipation in lipedema is rarely due to one single cause. Pain and reduced movement, rapid transition to low-carb eating, low fiber, fluid-electrolyte imbalance, stress, poor sleep, medications and microbiota changes can overlap. The safest approach is to treat bowel rhythm as a small but meaningful part of lipedema care, without unrealistic promises.

5/8/2026
5/8/2026
Mustafa SAÇAR
Prof.Dr. Mustafa SAÇARKalp ve Damar Cerrahisi UzmanıÖzel Cerrahi Hastanesi, Denizli, TURKEY

References

  1. Di Renzo, L., Frank, G., Pala, B., Cianci, R., De Santis, G. L., Nicoletti, F., Bigioni, G., Ortoman, M., Borro, M., Simmaco, M., Peluso, D., De Lorenzo, A., & Gualtieri, P. (2025). Characterization of gut microbiota profile in lipedema: A pilot study. Nutrients, 17(24), 3909. [https://doi.org/10.3390/nu17243909](https://doi.org/10.3390/nu17243909)https://doi.org/10.3390/nu17243909PMID: 41470854
  2. Xu, X., Wang, Y., Long, Y., & Cheng, Y. (2024). Chronic constipation and gut microbiota: Current research insights and therapeutic implications. Postgraduate Medical Journal, 100(1190), 890-897. [https://doi.org/10.1093/postmj/qgae112](https://doi.org/10.1093/postmj/qgae112)https://doi.org/10.1093/postmj/qgae112PMID: 39237119
  3. Zheng, F., Yang, Y., Lu, G., Tan, J. S., Mageswary, U., Zhan, Y., Ayad, M. E., Lee, Y.-Y., & Xie, D. (2025). Metabolomics insights into gut microbiota and functional constipation. Metabolites, 15(4), 269. [https://doi.org/10.3390/metabo15040269](https://doi.org/10.3390/metabo15040269)https://doi.org/10.3390/metabo15040269PMID: 40278398
  4. Chang, L., Chey, W. D., Imdad, A., Almario, C. V., Bharucha, A. E., Diem, S., Greer, K. B., Hanson, B., Harris, L. A., Ko, C., Murad, M. H., Patel, A., Shah, E. D., Lembo, A. J., & Sultan, S. (2023). American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological management of chronic idiopathic constipation. Gastroenterology, 164(7), 1086-1106. [https://doi.org/10.1053/j.gastro.2023.03.214](https://doi.org/10.1053/j.gastro.2023.03.214)https://doi.org/10.1053/j.gastro.2023.03.214PMID: 37211380

Comments (0)

Please log in to comment.

Login
Loading...